Prolonged Disease Course of COVID-19 in a Patient with CTLA-4 Haploinsufficiency

Patients with primary immunodeficiencies are especially vulnerable to developing severe coronavirus disease 2019 (COVID-19) after infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Cytotoxic T lymphocyte antigen-4 (CTLA-4) is an important regulator of immune responses,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffman, T. W., Leavis, H. L., Smits, B. M., van der Veken, L. T., van Kessel, D. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228224/
https://www.ncbi.nlm.nih.gov/pubmed/37260564
http://dx.doi.org/10.1155/2023/3977739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228224/
https://www.ncbi.nlm.nih.gov/pubmed/37260564
http://dx.doi.org/10.1155/2023/3977739

Ejemplares similares